ArticleDiagnostics (Basel, Switzerland)2026
An Immunohistochemistry-Based Molecular Subtyping Approach for Capturing Clinical Outcome Heterogeneity in Bladder Cancer.
Yuhan Chen, Lingkai Cai, Xiao Yang, Yiran Tao, Baorui Yuan, Zhengye Tan, Hao Yu, Meiling Bao, Qiang Lu
Abstract read
In one paragraphArticle in Diagnostics (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
9 authors.
Yuhan ChenDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Lingkai CaiDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Xiao YangDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Yiran TaoDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Baorui YuanDepartment of Pediatric Surgery, Women's Hospital of Nanjing Medical University (Nanjing Women and Children's Healthcare Hospital), Nanjing 210000, China.
Zhengye TanDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Hao YuDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Meiling BaoDepartment of Pathology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.
Qiang LuDepartment of Urology, The First Affiliated Hospital with Nanjing Medical University, Nanjing 210000, China.ORCID 0000-0003-3589-2507 Funding
China Postdoctoral Science Foundation 2024M761211Nanjing Postdoctoral Science Foundation funded project 2024BHS210National Natural Science Foundation of China 82273152National Natural Science Foundation of China 82503879Natural Science Foundation of Jiangsu Province BK20241128Noncommunicable Chronic Diseases-National Science and Technology Major Project 2024ZD0525700Special Research Fund of the Wu Jieping Medical Foundation 320.6750.2025-26-45
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
bladder cancerimmunohistochemistrymolecular subtyping
Identifiers
PMID42449837
PMCPMC13360000
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390